Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131326) titled 'Efficacy and Safety of XL-CTIT-PP Model-Guided Primary Prophylaxis With Romiplostim N01 for Oxaliplatin-Containing Chemotherapy-Induced Thrombocytopenia: A Clinical Study' on Sept. 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhongshan Hospital Affiliated to Xiamen University
Condition:
Oxaliplatin-containing chemotherapy-induced thrombocytopenia
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-09-01
Target Sample Size: Experimental group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3...